Causes of late mortality with dual antiplatelet therapy after coronary stents

AIMS: In the dual antiplatelet therapy (DAPT) study, continued thienopyridine beyond 12 months after drug-eluting stent placement was associated with increased mortality compared with placebo. We sought to evaluate factors related to mortality in randomized patients receiving either drug-eluting or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Heart J
Autori principali: Mauri, Laura, Elmariah, Sammy, Yeh, Robert W., Cutlip, Donald E., Steg, P. Gabriel, Windecker, Stephan, Wiviott, Stephen D., Cohen, David J., Massaro, Joseph M., D'Agostino, Ralph B., Braunwald, Eugene, Kereiakes, Dean J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751218/
https://ncbi.nlm.nih.gov/pubmed/26586780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv614
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi